to determine if aminoglycoside use and liver disease interact to cause an increased risk for renal dysfunction , data from 179 hospitalized patients who had been enrolled in a prospective , randomized trial of nafcillin/tobramycin versus cefotaxime were analyzed .
C0002556
aminoglycoside
C0040341
tobramycin